When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HEPA - Hepion Pharma advances lead candidate in early-stage study
Hepion Pharmaceuticals Inc.
Nano cap Hepion Pharmaceuticals (NASDAQ:HEPA) has advanced to the final dose level in a multiple oral ascending-dose Phase 1 clinical trial evaluating lead candidate CRV431 in healthy volunteers.
More news on: Hepion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,